COSIMO Ventures
4 Burton Hall Road, Sandyford, Dublin, D18, D18 Y8X2, Ireland
Overview
COSIMO Ventures is an emerging venture capital firm that focuses on early stage companies seeking to develop disruptive technology, primarily located in Ireland and the United Kingdom. COSIMO has offices in Boston, Massachusetts and Dublin, Ireland. Our Team have over 100 years of combined entrepreneurial operating and investing experience. We are technology pioneers resolute in our mission of helping emerging entrepreneurs build legendary companies. Our mission is to help transform the most promising early stage, Irish and UK technology companies into global leaders that will dominate new market categories or disrupt existing ones. We partner with management teams to help them accelerate and grow into the US market. COSIMO is a team of entrepreneurs that have been at the forefront of value creation for early stage companies over the past 25 years. As technology pioneers, we have developed products used by 100’s of millions of users every day and created many firsts; from the first commercially available financial service on the Internet to the first push notification.
- Total investments
- 4
- Lead investments
- 4
- Investments · 12mo
- 0
- Active investors
- 4
Sector focus
- Business Development
- Financial Services
- Health Care
- Medical Device
- Venture Capital
Investment portfolio
- Oneiro
Led · Series A · Oct 2019
Oneiro is a global provider of high-performance blockchain solutions based in Boston. The company develops blockchain infrastructure and services, including the Mainnet and technology underlying ndau, a buoyant digital currency built using COSMOS/Tendermint consensus. Under a service contract with the Axiom Foundation, Oneiro develops identity verification and autonomous transaction processing systems and other infrastructure for ndau. The new funding is intended to allow Oneiro to provide additional services to the Axiom Foundation and other clients, extend ndau into the digital asset economy, and perform global exchange integrations. Oneiro announced the appointment of Dhesi Ananchaperumal as CEO to lead its next phase of growth. To date, Oneiro has received $8 million in venture capital, including a $3 million seed in February 2018 and the newly announced $5 million Series A. Oneiro Ltd. is a blockchain technology firm focused on creating a global cryptocurrency designed and optimized for the long-term store of value. The company is developing technologies around decentralized, secure, and dependable cryptocurrency and positions its technology as integral to the market's future. Oneiro will have part of its core technology development team based in Dublin while establishing its operating headquarters in Boston, reflecting a trans-Atlantic strategy. COSIMO Ventures has committed $3 million as a seed investment to support the company’s development. The firm operates through Oneiro Ltd. and Oneiro NA Inc. and emphasizes leveraging experienced professionals across multiple markets. Oneiro intends to leverage best practices and lessons learned from markets to advance its cryptocurrency innovations.
- Gecko Governance
Led · Seed · Jan 2018
GECKO Governance has created a suite of blockchain-integrated products that let fund managers and banks schedule end-to-end compliance and regulatory tasks in a single platform while providing a verifiable, independent audit trail for regulators. Its platform offers live oversight of compliance requirements across use cases such as bank stress testing, operational due diligence, fund launches and investor onboarding, aiming to streamline operations and reduce costs. The company highlights integration flexibility and customization to fit each firm’s systems and best practices. GECKO says its solution improves operational efficiency by providing real-time, regulator-grade auditability. The company was founded in 2014 and operates from Dundalk (Ireland) with offices in New York and Sydney. GECKO has received recognition including winning the 2016 Seedcorn Competition and placing 10th in the RegTech 100 in 2017. It is also a Founding Member of the International RegTech Association (IRTA).
- Nova Leah
Led · Equity · Jun 2017
Nova Leah has developed SelectEvidence®, a cybersecurity compliance platform that manages cybersecurity throughout the lifetime of connected medical devices for manufacturers and healthcare providers. The platform offers a repeatable, traceable and auditable way to track risks for each device, highlight known vulnerabilities, recommend solutions and provide a feedback mechanism between manufacturers and hospitals. SelectEvidence® is designed to improve the security of connected medical devices, enhance patient safety and reduce associated regulatory costs. The platform has global deployments and a blue-chip customer base. The company intends to use the funds to continue to expand operations. Nova Leah is a spin-out from Dundalk Institute of Technology (DkIT) and is led by CEO Anita Finnegan; it is based in Dundalk, Ireland. Nova Leah develops SelectEvidence, a cybersecurity risk-management software built to help medical device manufacturers and healthcare providers implement and maintain device cybersecurity requirements. SelectEvidence was developed over a five-year R&D programme at Dundalk Institute of Technology. The company is initially targeting imaging and electro-medical device sectors in the US and maintains an office in Boston. Management is led by CEO Anita Finnegan and Lero researcher Dr Fergal McCaffery is a non-executive director. Nova Leah cites faster market deployment, reduced compliance costs and fewer recalls as key benefits and has early customers including Irish device manufacturer Orreco. Financially, the company rounded up €420,000 in funding including a €250,000 investment from Cosimo Venture Partners and a €172,000 Enterprise Ireland payment.